Lataa...
The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease
BACKGROUND: A first therapeutic target of somatic genome editing (SGE) is sickle cell disease (SCD), the most commonly inherited blood disorder, affecting more than 100,000 individuals in the United States. Advancement of SGE is contingent on patient participation in first in human clinical trials....
Tallennettuna:
| Julkaisussa: | AJOB Empir Bioeth |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7710006/ https://ncbi.nlm.nih.gov/pubmed/33044907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23294515.2020.1818876 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|